(IN BRIEF) EQT Life Sciences proudly announces Novo Nordisk's acquisition of Cardior Pharmaceuticals, valuing the biopharmaceutical company at up to…
(IN BRIEF) EQT Life Sciences announces the acquisition of its portfolio company, Amolyt Pharma, by Alexion, AstraZeneca Rare Diseases, for…
(IN BRIEF) Tubulis has closed an oversubscribed €128 million ($138.8 million) Series B2 financing round, co-led by EQT Life Sciences…
(IN BRIEF) Phagenesis, a UK-based medical technology company specializing in treating swallowing disorders, has closed a significant $42 million Series…
(IN BRIEF) Onera Health, a leader in sleep diagnostic and monitoring solutions, has successfully completed a €30 million ($32 million)…
(PRESSEMITTEILUNG) STOCKHOLM, 1-Mar-2022 — /EuropaWire/ — EQT, eine zweckorientierte globale Investmentorganisation, hat die Gründung eines neu gegründeten Unternehmens bekannt gegeben…
(PRESS RELEASE) STOCKHOLM, 1-Mar-2022 — /EuropaWire/ — EQT, a purpose-driven global investment organization, has announced the establishment of a newly…
LSP will strengthen EQT’s position as one of the leading and most active private markets investors in the healthcare sector.…